1. Morbidity of adult population of Russia in 2012: The statistical material. Moscow; 2012. (in Russian)
2. European guidelines on CVD prevention. Version 2012. ESC.
3. Butt H.R., Allen E.V., Bollman J.L. A preparation from spoiled sweet clover (3,3-methylen-bis-(4-hydroxycoumarin) which prolongs coagulation and prothrombin time of blood: Preliminary report of experimental and clinical studies. Proc. Staff Meet. Mayo Clin. 1941; 16: 338.
4. Carrier M., Le Gal G., Wells P. et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann. Intern. Med. 2010; 152 (9): 578—89.
5. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N. Engl. J. Med. 1990; 323: 1505—11.